Latest news

Commercial

Lilly to Acquire Kelonia for Up to $7 Billion, Adding Phase 1 In Vivo CAR-T Therapy

Eli Lilly has entered into an agreement to acquire Kelonia Therapeutics in a transaction valued at up to $7...
Regulatory

Roche Initiates Phase III Study of Elevidys Following EMA Feedback

Roche said that it is initiating a late-stage clinical trial of its gene therapy Elevidys for Duchenne muscular dystrophy...
Insights

Top 10 Pharma News Websites You Should Follow in 2026

Executive Summary In 2026, pharma and biotech are evolving at unprecedented speed. AI-driven drug discovery, digital transformation, personalized medicine, and...
Insights

How Are Life Sciences Companies Raising Capital in 2026?

Executive Summary In 2026, raising capital in life sciences is no longer about access—it is about proof. The traditional reliance...
Commercial

Keebler Raises $16 Million Series A to Advance AI-Based Risk Adjustment Platform

Artificial intelligence startup Keebler Health has secured $16 million...
Commercial

BMS and Bain Capital Launch Beeline Medicines with Autoimmune Pipeline Led by Afimetoran

A new biotechnology company, Beeline Medicines, has emerged from...
Insights

Can AI Predict Regulatory Outcomes in Pharma and Biotech?

Executive Summary AI can partially predict regulatory outcomes in pharma and biotech, but it cannot replace regulatory judgment. In 2026,...
Insights

Market Access Challenges in Pharmaceuticals: Pricing, Policy, and Payer Pressure

Executive Summary Market access challenges in pharmaceuticals in 2026 are defined by increasing pricing pressure, evolving policy frameworks, and more...
Insights

Why Is Market Access Becoming More Difficult for Pharma Companies?

Executive Summary Market access is becoming more difficult for pharma companies in 2026 due to a convergence of pricing pressure,...
Insights

Launch Readiness in Pharma: Overcoming Market Entry Barriers

Executive Summary Launch readiness in pharma in 2026 is defined...
Insights

What Commercial Strategy Mistakes Do Biotech Companies Make?

Executive Summary Biotech companies in 2026 most commonly fail commercially...
Insights

The Role of AI and Data in Driving Pharma Innovation

Executive Summary AI and data are now central to driving pharma innovation in 2026, fundamentally reshaping how therapies are discovered,...
Insights

Innovation vs Regulation in Life Sciences: Can Companies Balance Both?

Innovation vs Regulation:Executive Summary Yes—life sciences companies can balance innovation and regulation in 2026, but only by integrating regulatory strategy...
Insights

Responding to Patent Expirations and Generic Competition

Executive Summary Patent expiration refers to the end of market exclusivity, after which generic or biosimilar competitors can enter. Pharma...
Regulatory

Roche Initiates Phase III Study of Elevidys Following EMA Feedback

Roche said that it is initiating a late-stage clinical...
Editorial Team -
Commercial

Gilead Sciences Broadens Scope with $1.7 Billion Partnership with Leo Pharma

Gilead Sciences is further extending its reach beyond its...
Commercial

Novartis Acquires DTx Pharma in a Deal Potentially Worth $1B

Swiss pharmaceutical firm Novartis said on Monday that it...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team -

Regulatory

Regulatory

Roche Initiates Phase III Study of Elevidys Following EMA Feedback

Roche said that it is initiating a late-stage clinical...
Editorial Team -
Regulatory

Roche Initiates Phase III Study of Elevidys Following EMA Feedback

Roche said that it is initiating a late-stage clinical...
Insights

Top 10 Pharma News Websites You Should Follow in 2026

Executive Summary In 2026, pharma and biotech are evolving at...
Insights

How Are Life Sciences Companies Raising Capital in 2026?

Executive Summary In 2026, raising capital in life sciences is...
Research & Development

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Kailera Therapeutics has provided additional details regarding its planned...

Research & Development

Market Access

Manufacturing

Lilly’s Plan to Build $3B Dutch Plant Underway, 500 Hires Also in the Pipeline

Eli Lilly Expands European Manufacturing with a $3 Billion...
Manufacturing

Alkermes plans to acquire Avadel and its long-acting narcolepsy medication Lumryz for $2.1 billion

Alkermes, which plans to spend up to $2.1 billion...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Manufacturing

UCB to Build $2 Billion Biologics Manufacturing Facility in Georgia

Belgium-based UCB has announced plans to invest $2 billion...
Editorial Team -
Insights

Top 10 Pharma News Websites You Should Follow in 2026

Executive Summary In 2026, pharma and biotech are evolving at...
Editorial Team -